OVERVIEW

How Can We Leverage Current Evidence for Nonfactor Therapies to Improve QOL and Patient Outcomes in Hemophilia? Practical Essentials for Community Hematology is organized by Integrity Continuing Education Inc. and will be held on Dec 01, 2025.

Description:
Despite progress in hemophilia care, challenges like breakthrough bleeds, joint damage, chronic pain, and reduced quality of life remain. These issues affect daily function, social engagement, and mental well-being, underscoring the need for innovative solutions. This educational program explores the rationale behind nonfactor and emerging therapies for hemophilia A and B, backed by the latest clinical trial data. Participants will gain expert, multidisciplinary insights and practical strategies to confidently design personalized treatment regimens, empowering providers to elevate care for patients who may benefit most from these advanced therapeutic options.

Learning objectives:
Upon completion of this educational activity, participants should be able to:

Assess clinical data with nonfactor and other novel therapies for patients with hemophilia and the potential to address unmet medical needs
Formulate treatment plans for clinical scenarios of patients with hemophilia, incorporating patient lifestyle considerations
Discuss implications of nonfactor therapies for the multidisciplinary healthcare team regarding treatment administration and monitoring of patients with hemophilia
Describe optimal approaches to manage treatment-related adverse events associated with emerging therapeutic approaches in hemophilia.